Condition: Schizophrenia · Sponsor: Boryung Pharmaceutical Co., Ltd
The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia
This description comes directly from the study's public registry record.
Shin-young Oh · +82+2-708-8000 · syoh@boryung.co.kr
Always discuss trial participation with your own doctor first.
| Kyungbook National university hospital | Daegu, South Korea | Recruiting |
| Hanyang University Guri Hospital | Guri-si, South Korea | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06821945